High-priority drugedrug interactions for use in electronic health records

Journal of the American Medical Informatics Association

Volumn 19, Issue 5, 2012, Pages 735-743

  Phansalkar, Shobha ^a,b,c   Desai, Amrita A ^c   Bell, Douglas ^d,e   Yoshida, Eileen ^c   Doole, John ^c   Czochanski, Melissa ^c   Middleton, Blackford ^a,b,c   Bates, David W ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS HEALTHCARE   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATAZANAVIR; CERIVASTATIN; CIPROFLOXACIN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; FLUOXETINE; FLUVOXAMINE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRINOTECAN; KETOCONAZOLE; LINEZOLID; METFORMIN; MONOAMINE OXIDASE INHIBITOR; NARCOTIC ANALGESIC AGENT; PROCARBAZINE; RAMELTEON; RIFAMPICIN; RITONAVIR; SELEGILINE; SILDENAFIL; TADALAFIL; TIZANIDINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VARDENAFIL;

ARTICLE; DECISION SUPPORT SYSTEM; ELECTRONIC MEDICAL RECORD; HEALTH CARE FACILITY; HUMAN; KNOWLEDGE; RISK BENEFIT ANALYSIS; RISK FACTOR; COMPUTER ASSISTED DRUG THERAPY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; HOSPITAL INFORMATION SYSTEM; HOSPITAL ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG INTERACTIONS; DRUG THERAPY, COMPUTER-ASSISTED; ELECTRONIC HEALTH RECORDS; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; MEDICATION SYSTEMS;

EID: 84872245501     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2011-000612     Document Type: Article

References (27)

1. Terrell KM, Perkins AJ, Dexter PR, et al. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: a randomized, controlled trial. J Am Geriatr Soc 2009;57:1388e94.
2. Tamblyn R, Huang A, Taylor L, et al. A randomized trial of the effectiveness of ondemand versus computer-triggered drug decision support in primary care. J Am Med Inform Assoc 2008;15:430e8.
3. Kuperman GJ, Bobb A, Payne TH, et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007;14:29e40.
4. Taylor LK, Tamblyn R. Reasons for physician non-adherence to electronic drug alerts. Stud Health Technol Inform 2004;107:1101e15.
5. Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc 2006;13:5e11.
6. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006;13:138e47.
7. Paterno MD, Maviglia SM, Gorman PN, et al. Tiering drug-drug interaction alerts by severity increases compliance rates. J Am Med Inform Assoc 2009;16:40e6.
8. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) 2004;44:136e41.
9. Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 2007;63:709e14.
10. Hansten PD, Horn JR, Hazlet TK. ORCA: OpeRational ClassificAtion of drug interactions. J Am Pharm Assoc (Wash) 2001;41:161e5.
11. Aspden P, Wolcott JA, Bootman JL, et al, eds. Preventing Medication Errors. Washington, DC: National Academies Press, 2006.
12. Sittig DF, Wright A, Simonaitis L, et al. The state of the art in clinical knowledge management: an inventory of tools and techniques. Int J Med Inform 2010;79:44e57.
13. Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003) 2004;44:142e51.
14. Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med 2009;169:305e11.
15. Hansten PD, Horn JR. The Top 100 Drug Interactions. A Guide to Patient Management. 2010 edn. Edmonds, Washington: H&H publications, 2001.
16. http://medicine.iupui.edu/clinpharm/ddis/table.asp
17. Wang LM, Wong M, Lightwood JM, et al. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother 2010;44:28e34.
18. Wong CM, Ko Y, Chan A. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Ann Pharmacother 2008;42:1737e48.
19. Patel N, Abdelsayed S, Veve M, et al. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. Ann Pharmacother 2011;45:317e24.
20. Preskorn SH, Shah R, Neff M, et al. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline. J Psychiatr Pract 2007;13:5e12.
21. http://www.azcert.org/medical-pros/druginteractions.cfm (accessed 26 Jul 2011).
22. Phansalkar S, Wright A, Kuperman GJ, et al. Towards meaningful medicationrelated clinical decision support: recommendations for an initial implementation. Appl Clin Inform 2011;2:50e62.
23. Classen DC, Phansalkar S, Bates DW. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches. J Patient Saf 2011;7:61e5.
24. Bodenreider O, Fushman DD. Investigating drug classes in biomedical terminologies from the perspective of clinical decision support. AMIA Annu Symp Proc 2010;2010:56e60.
25. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm
26. Olvey EL, Clauschee S, Malone DC. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Clin Pharmacol Ther 2010;87:48e51.
27. Boyce R, Collins C, Horn J, et al. Computing with evidence Part II: an evidential approach to predicting metabolic drug-drug interactions. J Biomed Inform 2009;42:990e1003.